Drug
Triamcinolone Acetonide Extended-release Injectable Suspension
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Therapeutic Response Shortened | 44 | 33.8 | 35.6 | signal |
| 2 | Joint Stiffness | 13 | 12.1 | 12.3 | signal |
| 3 | Ocular Discomfort | 5 | 11.2 | 11.3 | signal |
| 4 | Product Use Complaint | 7 | 11.0 | 11.1 | signal |
| 5 | No Adverse Event | 78 | 10.7 | 11.7 | signal |
| 6 | Joint Swelling | 47 | 9.5 | 10.0 | signal |
| 7 | Drug Effect Less Than Expected | 5 | 8.7 | 8.7 | signal |
| 8 | Blood Thyroid Stimulating Hormone Increased | 3 | 7.9 | 8.0 | signal |
| 9 | Affect Lability | 3 | 7.6 | 7.6 | signal |
| 10 | Expired Product Administered | 8 | 5.9 | 5.9 | signal |
| 11 | Synovitis | 3 | 4.1 | 4.1 | signal |